Pàgina inicial > Resultats de la cerca: Litzow, M.R.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
34 p, 950.5 KB Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies / Pasquini, Marcelo (Medical College of Wisconsin) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Medeiros, Bruno (Stanford University School of Medicine) ; Armand, Philippe (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Hu, Zhen-Huan (Medical College of Wisconsin) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Aljurf, Mahmoud D. (King Faisal Specialist Hospital Center and Research) ; Akpek, Görgün (Banner MD Anderson Cancer Center) ; Cahn, Jean-Yves (University Hospital) ; Cairo, Mitchell S. (New York Medical College) ; Cerny, Jan (UMass Memorial Medical Center) ; Copelan, Edward A. (Carolinas HealthCare System) ; Deol, Abhinav (Wayne State University) ; Freytes, César O. (University of Texas Health Science Center San Antonio) ; Gale, Robert Peter (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Medical Center) ; George, Biju (Christian Medical College) ; Gupta, Vikas (University Health Network) ; Hale, Gregory A. (All Children's Hospital) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Klumpp, Thomas R. (Thomas Jefferson University Hospital) ; Lazarus, Hillard M. (University Hospitals Case Medical Center) ; Luger, Selina M. (University of Pennsylvania Medical Center) ; Liesveld, Jane L. (University of Rochester Medical Center) ; Litzow, Mark Robert (Mayo Clinic) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Norkin, Maxim (University of Florida College of Medicine) ; Olsson, Richard F. (Uppsala University) ; Oran, Betul (The University of Texas MD Anderson Cancer Center) ; Pawarode, Attaphol (University of Michigan) ; Pulsipher, Michael A. (University of Southern California Keck School of Medicine) ; Ramanathan, Muthalagu (UMass Memorial Medical Center) ; Reshef, Ran (University of Pennsylvania Medical Center) ; Saad, Ayman A. (University of Alabama at Birmingham) ; Saber, Wael (Medical College of Wisconsin) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Schouten, Harry C. (Academische Ziekenhuis) ; Ringdén, Olle (Centre for Allogeneic Stem Cell Transplantation) ; Tallman, Martin S. (Memorial Sloan Kettering Cancer Center) ; Uy, Geoffrey L. (Washington University School of Medicine) ; Wood, William A. (University of North Carolina) ; Wirk, Baldeep (Seattle Cancer Care Alliance) ; Pérez, Waleska S. (Medical College of Wisconsin) ; Batiwalla, Minoo (National Heart Lung and Blood Institute - National Institutes of Health) ; Weisdorf, Daniel J. (University of Minnesota Medical Center) ; Universitat Autònoma de Barcelona
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. [...]
2016 - 10.1016/j.bbmt.2015.08.024
Biology of blood and marrow transplantation, Vol. 22 Núm. 2 (january 2016) , p. 248-257  
Registre complet - Creative Commons
2.
7 p, 820.3 KB Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation / Stein, A. S. (Gehr Family Center for Leukemia Research. City of Hope) ; Kantarjian, H. (The University of Texas M.D. Anderson Cancer Center) ; Gökbuget, N. (Department of Medicine II. Goethe University) ; Bargou, R. C. (Comprehensive Cancer Center Mainfranken. University Hospital Würzburg) ; Litzow, Mark R (Mayo Clinic) ; Rambaldi, Alessandro (Department of Oncology and Hemato-Oncology. University of Milan and Azienda Pope John XXIII Hospital) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zhang, A. (Amgen Inc.) ; Zimmerman, Z. (Amgen Inc.) ; Zugmaier, Gerhard (Amgen Research Munich) ; Topp, M. S. (Medical Clinic and Polyclinic II. University Hospital Würzburg) ; Universitat Autònoma de Barcelona
Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) following allogeneic hematopoietic stem cell transplantation (alloHSCT) have a poor prognosis, and alternative therapies are needed for this patient population. [...]
2019 - 10.1016/j.bbmt.2019.04.010
Biology of blood and marrow transplantation, Vol. 25 Núm. 8 (august 2019) , p. 1498-1504  
Registre complet - Creative Commons
3.
13 p, 850.9 KB Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation / Chhabra, Saurabh (Medical College of Wisconsin) ; Liu, Ying (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Costa, Luciano (University of Alabama at Birmingham. Department of Medicine) ; Pidala, Joseph A. (H. Lee Moffitt Cancer Center and Research Institute) ; Couriel, Daniel R. (Utah Blood and Marrow Transplant Program) ; Alousi, Amin M. (University of Texas MD Anderson Cancer Center) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Stuart, Robert K. (Medical University of South Carolina) ; Kim, Dennis (Princess Margaret Cancer Center) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia). Division of Therapeutic Immunology) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saad, Ayman (University of Alabama at Birmingham) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Cooper, Brenda (University Hospitals Case Medical Center. Department of Medicine-Hematology and Oncology) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Socie, Gerard (Hôpital Saint Louis. Department of Hematology) ; Schouten, Harry C. (Academische Ziekenhuis. Department of Hematology) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Yared, Jean (University of Maryland. Greenebaum Cancer Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes. Department of Hematology) ; Wagner, John (Thomas Jefferson University. Department of Medical Oncology) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Verdonck, Leo F. (Isala Clinic. Departmentt of Hematology/Oncology) ; Lehmann, Leslie (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; MacMillan, Margaret L. (University of Minnesota Blood and Marrow Transplant Program) ; Litzow, Mark R. (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Solh, Melhem M. (Northside Hospital. Blood and Marrow Transplant Group of Georgia) ; Qayed, Muna (Emory University School of Medicine. Department of Pediatrics) ; Hematti, Peiman (University of Wisconsin) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Vij, Ravi (Washington University School of Medicine. Division of Hematology and Oncology) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis. Division of Pediatric Hematology/Oncology) ; Gale, Robert Peter (Imperial College London. Hematology Research Centre) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Seo, Sachiko (National Cancer Research Center East) ; Hashmi, Shahrukh K (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Teshima, Takanori (Kyushu University Hospital) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center. Department of Medical Oncology) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Spellman, Stephen R. (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (alloHCT), but there are limited data comparing efficacy of the 2 regimens. [...]
2019 - 10.1016/j.bbmt.2018.08.018
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 73-85  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
3 Litzow, M.
5 Litzow, Mark
1 Litzow, Mark R
1 Litzow, Mark R.
1 Litzow, Mark Robert
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem